CATIE (Image: CATIE) Health Canada recently approved the use of the drug cabotegravir (Apretude) as the first long-acting form of pre-exposure prophylaxis (PrEP) to prevent HIV infection. Until now, PrEP has been available as pills taken daily or on demand. Oral PrEP is highly effective at preventing HIV when taken as prescribed.  When taken as PrEP, … Continuer la lecture de Research Update: Long-acting injectable PrEP approved for HIV prevention